Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans
Download from source ↗Dataset overview
Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans.
Abstract
A mysterious feature of Crohn's disease (CD) is the extra-intestinal manifestation of "creeping fat" (CrF), defined as expansion of mesenteric adipose tissue around the inflamed and fibrotic intestine. In the current study, we explore whether microbial translocation in CD serves as a central cue for CrF development. We discovered a subset of mucosal-associated gut bacteria that consistently translocated and remained viable in CrF in CD ileal surgical resections, and identified Clostridium innocuum as a signature of this consortium with strain variation between mucosal and adipose isolates, suggesting preference for lipid-rich environments. Single-cell RNA sequencing characterized CrF as both pro-fibrotic and pro-adipogenic with a rich milieu of activated immune cells responding to microbial stimuli, which we confirm in gnotobiotic mice colonized with C. innocuum. Ex vivo validation of expression patterns suggests C. innocuum stimulates tissue remodeling via M2 macrophages, leading to an adipose tissue barrier that serves to prevent systemic dissemination of bacteria.
doi:10.1016/j.cell.2020.09.009 ↗ PMID 32991841 ↗ PMC7521382 ↗
Study facts
- Organism
- Homo sapiens
- Platform
- 10x Genomics Chromium and Bio-Rad SureCell
- Age group
- adult
- Disease groups
- Non-IBD controls, Ulcerative colitis
- Anatomical sites
- —
Data availability
- Analysis code
Strengths & limitations for reuse
Strengths
- Raw reads are advertised
- Analysis code is available
Limitations
- Not documented: feature/otu tables are advertised
- Not documented: taxonomic tables are advertised
- Not documented: participant counts are documented
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.platform |
10x Genomics Chromium and Bio-Rad SureCell |
SureCell samples: healthy and inflamed tissue from 3 Crohn's disease patients, 2 ulcerative colitis patients Chromium samples: 2 Crohn's disease patients, 2 non-IBD controls. Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.age_group |
adult |
Exclusion criteria included patients under 18, unwilling to provide informed consent, antibiotic or antifungal use in the six weeks prior to surgery, or individuals with colorectal cancer or undergoing chemoradiation therapy. Section |
cohort.non_ibd_controls |
2 |
Chromium samples: 2 Crohn's disease patients, 2 non-IBD controls. Section |
cohort.study_design |
cross_sectional inferred |
patients undergoing surgical resections due to complications from CD Section |
cohort.ulcerative_colitis_participants |
2 |
SureCell samples: healthy and inflamed tissue from 3 Crohn's disease patients, 2 ulcerative colitis patients Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.analysis_code |
True |
scRNA-seq codes are available on Github Section |
data_assets.open_access |
True from source |
"isOpenAccess": "Y" Section |
data_assets.pipeline_or_tool_versions |
True |
Cell Ranger v3.1.0 Section |
data_assets.raw_reads |
True |
All of the DNA and RNA sequencing datasets generated in this study have been deposited to NCBI. Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.body_site |
mesenteric adipose tissue |
Whole blood, resected intestinal tissue, and attached mesenteric adipose were aseptically collected Section |
specimens.inflamed_status_available |
True |
healthy and inflamed tissue from 3 Crohn's disease patients, 2 ulcerative colitis patients Section |